Search

Search Results

• PO:20:002 | Respiratory function tests predict bone mineral density in autoimmune rheumatic disease patients Andrea Zoli¹, Panagiotis Garantziotis², Sebastian Böltz², Janina Auth², Sara Bayat², Jule Taubmann², Anna-Maria Liphardt², Maria Antonietta D'Agostino¹, Christina Bergmann², Georg Schett². | ¹Division of Rheumatology, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy; ²Department of Medicine 3, Rheumatology and Immunology, Friedrich Alexander Universität FAU, Erlangen, Germany.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2050

  147

• PO:27:112 | The impact of rurality in chronic inflammatory rheumatic diseases in the province of Udine (2014-2023): analysis of clinical outcomes and potential complications Simone Longhino¹, Luigi Castrista², Yvonne Beorchia², Marco Driutti², Elena Treppo¹, Silvio Brusaferro³, Luca Quartuccio¹ | ¹Clinica di Reumatologia, Dipartimento di Medicina Specialistica; ²Istituto di Igiene ed Epidemiologia Valutativa; ³Accreditamento, Gestione del Rischio Clinico e Valutazione delle Performance Sanitarie, ASUFC, Udine, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2196

  159

• PO:12:178 | Don't count your chickens before they hatch! Analysis of cardiovascular definitions in studies on rheumatic diseases: a systematic literature review Laura Pezzoni¹, Silvia Sirotti^1|2, Georgios Filippou^1|2, Piercarlo Sarzi Puttini^1|2, Greta Pellegrino^1|2. | ¹Università degli Studi di Milano, Milano; ²IRCCS Ospedale Galeazzi Sant'Ambrogio, Milano, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2028

  148

• PO:12:187 | Maternal Hypertensive Disorders in Pregnant Women with Rheumatic Diseases and long-term Cardiovascular Outcomes: preliminary data of a single centre experience Margherita Rinaldi¹, Paolo Semeraro¹, Francesca Crisafulli¹, Matteo Filippini², Maria Grazia Lazzaroni¹, Cecilia Nalli¹, Liala Moschetti¹, Marco Taglietti², Chiara Loardi³, Rossana Orabona³, Francesca Ramazzotto³, Sonia Zatti³, Laura Andreoli¹, Angela Tincani¹, Micaela Fredi¹, Ilaria Cavazzana¹, Franco Franceschini¹ | ¹Department of Clinical and Experimental Sciences, University of Brescia, Italy; ²Rheumatology and Clinical Immunology, ASST Spedali Civili of Brescia, ERN-ReCONNET Center Brescia, Italy; ³Gynaecology and Obstetrics Unit ASST Spedali Civili di Brescia, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2317

  36

• PO:27:106 | Role of histology in interstitial lung involvement of rheumatic diseases in real life scenario Francesca Cozzini^1|2, Francesco Falco¹, Lucia Spaggiari^1|3, Alberto Cavazza¹, Adele Del Giudice^1|2, Lucia Dardani¹, Fabio Brandolino¹, Emanuele Cocchiara¹, Ilaria Chiapparoli¹, Luca Magnani⁴, Gianluigi Bajocchi¹, Carlo Salvarani^1|2, Andreina Manfredi^1|2 | ¹IRCCS Arcispedale Santa Maria Nuova Reggio Emilia, Italy; ²Università degli Studi di Modena e Reggio Emilia Modena, Italy; ³AUSL area NORD Montecchio-Guastalla, Italy; ⁴UOC di Medicina Interna ad Indirizzo Reumatologico, Azienda USL Bologna, Ospedale Maggiore Bologna, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2358

  42

• PO:26:097 | Ultrasound evaluation of temporomandibular disorders: comparative analysis between inflammatory and degenerative patterns in patients with and without rheumatological pathologies Beatrice Maranini¹, Stefano Mandrioli², Fabio Fabbian³, Tommaso Bianchi¹, Manlio Galiè², Marcello Govoni¹ | ¹UO di Reumatologia, Dipartimento di Scienze Mediche, Università di Ferrara; ²UO di Chirurgia Maxillo-Facciale, Dipartimento Testa-Collo, Università di Ferrara; ³Dipartimento di Scienze Mediche, Università di Ferrara, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2193

  153

• CO:09:6 | Risk of disease flare during pregnancy and postpartum in inflammatory arthritis: association with therapy discontinuation in the prospective P-RHEUM.it study Dina Zucchi¹, Chiara Tani¹, Francesca Crisafulli², Alessia Gatti², Maria Gerosa³, Cecilia Chighizola³, Melissa Padovan⁴, Salvatore D'Angelo⁵, Florenzo Iannone⁶, Maria Sole Chimenti⁷, Claudia Lomater⁸, Francesca Serale⁹, Veronique Ramoni¹⁰, Oscar Epis¹¹, Bernd Raffeiner¹², Ariela Hoxha¹³, Andrea Doria¹⁴, Leonardo Santo¹⁵, Valentina Canti¹⁶, Francesca Bellisai¹⁷, Giovanna Cuomo¹⁸, on behalf of the P-Rheumit Investigators¹⁹, Greta Carrara²⁰, Cristina Di Nicola²⁰, Davide Rozza²⁰, Carlo Alberto Scirè²⁰, Maria Chiara Gerardi¹¹, Angela Tincani², Laura Andreoli², Marta Mosca¹. | ¹Rheumatology Unit, University of Pisa and Azienda Ospedaliero Universitaria Pisana; ²Rheumatology and Clinical Immunology Unit, ASST Spedali Civili, Brescia; ³Clinical Rheumatology Division, ASST Gaetano Pini-CTO and University of Milano; ⁴Rheumatology Unit, Azienda Ospedaliero-Universitaria S. Anna and University of Ferrara; ⁵Rheumatology Department of Lucania - San Carlo Hospital, Potenza; ⁶Rheumatology Unit, DiMePRE-J, University of Bari; ⁷Department of Systems Medicine, Rheumatology, Allergology and Clinical Immunology, University of Rome-Tor Vergata, Roma; ⁸Torino Academic Rheumatology Center, A.O. Mauriziano di Torino, University of Torino; ⁹Rheumatology Unit, ASL CN1 Cuneo; ¹⁰Internal Medicine Department, ASST Lodi - Ospedale Maggiore di Lodi; ¹¹Division of Rheumatology, Multispecialist Medical Department, Grande Ospedale Metropolitano Niguarda, Milano; ¹²Department of Rheumatology, Central Hospital of Bolzano SABES-ASDAA, Bolzano; ¹³General Medicine and Thrombosis and Hemorrhagic Unit, Department of Medicine, University of Padova; ¹⁴Rheumatology Unit, Department of Medicine, University of Padova; ¹⁵Rheumatology Unit, Mons. Dimiccoli Hospital, Barletta; ¹⁶Division of Immunology, Transplantation and Infectious Diseases, IRCCS Ospedale San Raffaele, Milano; ¹⁷Rheumatology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena; ¹⁸Precision Medicine Department, University of Campania L. Vanvitelli, Napoli; ¹⁹The Italian Society for Rheumatology; ²⁰Epidemiology Research Unit of the Italian Society for Rheumatology, Milano, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.1989

  153

• PO:08:124 | An exploratory analysis of risk factors for methotrexate-associated osteopathy: a retrospective study Federico Aldegheri¹, Francesca Ruzzon¹, Matteo Appoloni¹, Maurizio Rossini¹, Giovanni Adami¹, Davide Gatti¹, Ombretta Viapiana¹, Angelo Fassio¹ | ¹Università di Verona, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2308

  32

• PO:24:065 | Nailfold capillaroscopic in primary Sjögren's syndrome, clinical and serological correlations; a preliminary report from a reference center Caterina Vacchi¹, Filippo Santoro¹, Maria Grazia Malandra¹, Giulia Cassone¹, Alessandra Carobbio², Martina Orlandi¹, Dilia Giuggioli¹ | ¹Reumatologia Modena, Italy; ²Statistica Medica Modena, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2352

  20

• CO:10:2 | Common variable immunodeficiency patients complicated by autoimmune and inflammatory rheumatic manifestations reveal high frequency of genetic variants potentially linked to inborn errors of immunity Paolo Semeraro¹, Micol Frassi¹, Silvia Clara Giliani², Franco Franceschini¹, Paolo Airò¹. | ¹Rheumatology and Clinical Immunology Unit, ERN ReCONNET, ASST Spedali Civili of Brescia and University of Brescia; ²Medical Genetic Laboratory, ASST Spedali Civili of Brescia and University of Brescia, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.1991

  144

• PO:07:103 | Tocilizumab use in patients with rheumatoid arthritis and malignancy: a monocentric experience Vittorio Dibenedetto^1|2|3, Nicola Farina^1|2, Nicola Boffini^1|2, Alessandro Tomelleri^1|2, Adriana Cariddi^1|2, Elena Baldissera^1|2, Marco Matucci-Cerinic^1|2|3, Lorenzo Dagna^1|2|3. | ¹Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milano, Italy; ²Inflammation, Fibrosis and Ageing Intitiative ^INFLAGE, IRCCS San Raffaele Hospital, Milano, Italy; ³Vita-Salute San Raffaele University, Milano, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2021

  137

• PO:33:190 | Travel distance to tertiary healthcare reflects disease severity and medication access in systemic sclerosis patients: insights from the Italian systemic sclerosis progression investigation registry of the Italian Society of Rheumatology Camilla Teresa Magnanimi¹, Enrico De Lorenzis¹, Gerlando Natalello¹, Fabio Cacciapaglia², Rossella De Angelis³, Edoardo Cipolletta³, Maria Antonietta D'Agostino¹, Veronica Cudullo⁴, Giacomo De Luca⁵, Dilia Giuggioli⁶, Francesca Ingegnoli⁷, Valeria Riccieri⁸, Lorenzo Dagna⁵, Fiorenzo Iannone⁹, Clodoveo Ferri⁶, Marco Matucci Cerinic⁵, Silvia Laura Bosello¹. | ¹Division of Rheumatology and Clinical Immunology, Catholic University of the Sacred Heart, Fondazione Policlinico Univer, Roma, Italy; ²Department of Medicine and Surgery, LUM University Giuseppe De Gennaro Casamassima e Rheumatology Service Miulli Ge, Bari, Italy; ³Rheumatology Unit - Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy; ⁴Department of Rheumatology, Policlinico San Matteo, Pavia, Italy; ⁵Unit of Immunology, Rheumatology, Allergy and Rare Diseases ^UnIRAR, IRCCS San Raffaele Scientific Institute, Vita-Salu, Milano, Italy; ⁶Rheumatology Unit, School of Medicine, University of Modena and Reggio Emilia, Modena, Italy; ⁷Division of Clinical Rheumatology, ASST Pini, Dept. of Clinical Sciences e Community Health, Research Center for Adult a, Milano, Italy; ⁸Department of Rheumatology, La Sapienza University of Rome, Roma, Italy; ⁹Rheumatology Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari, Bari, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2081

  166

• PO:24:064 | IPF vs CTD-ILD: Survival and Lung Function from an Italian Real-World Cohort Marco Fornaro¹, Donato Lacedonia², Lorenzo Cavagna³, Paolo Airò⁴, Marco Sebastiani⁵, Gianluca Sambataro⁶, Fabio Cacciapaglia⁷, Angelica Napoletano¹, Cosimo De Pace², Pasquale Tondo², Giulia Scioscia², Eleonora Pedretti⁴, Maria Grazia Lazzaroni⁴, Carlo Vancheri⁸, Andreina Manfredi⁹, Lorenzo Binchessi³, Rocco Capece³, Michele De Ceglie¹⁰, Massimo Giotta¹¹, Florenzo Iannone¹ | ¹Unit of Rheumatology, Department of Precision and Regenerative Medicine - Area Jonica DiMePRe-J, University of Bari, Bari, Italy; ²Department of Medical and Surgical Sciences, University of Foggia Foggia, Italy; ³Department of Internal Medicine and Therapeutics, University of Pavia, Division of Rheumatology, Fondazione IRCCS, Pavia, Italy; ⁴Rheumatology and Clinical Immunology Unit, Department of Clinical and Experimental Sciences, ASST Spedali Civili Brescia, Italy; ⁵Rheumatology Unit, AUSL Piacenza, Department of Medicine and Surgery, University of Parma, Parma, Italy; ⁶Department of Medicine and Surgery, University of Enna Kore, Enna, Italy; ⁷Rheumatology Service, F. Miulli Hospital and Department of Medicine and Surgery, LUM University, Casamassima, Italy; ⁸Department of Clinical and Experimental Medicine, Regional Referral Center for Rare Lung Diseases, Catania, Italy; ⁹Rheumatology Unit, IRCCS Santa Maria Nuova Reggio Emilia, University of Modena, Modena, Italy; ¹⁰DIM, Interdisciplinary Department of Medicine, Section of Diagnostic Imaging, University of Bari, Bari, Italy; ¹¹Health Prevention Department, Local Health Authority of Brindisi, Brindisi, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2351

  31

• PO:06:093 | Clinical and ultrasound phenotyping comparison between Difficult-To-Treat Rheumatoid Arthritis (D2TRA) and non-D2TRA patients: experience from a monocentric cohort Silvia Perrone¹, Claudio Cruciani¹, Silvia Mascolo¹, Elisa Bellis¹, Gloria Crepaldi¹, Valeria Data¹, Claudia Garulli¹, Claudia Lomater¹, Elena Marucco¹, Marta Saracco¹, Mariele Gatto¹, Annamaria Iagnocco¹. | ¹Academic Rheumatology Centre, Department of Clinical and Biological Sciences, University of Turin, AO Mauriziano, Turin, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2018

  131

• PO:02:025 | Real-World Comparative Effectiveness of Upadacitinib in Psoriatic Arthritis: Evaluation of Switching to Upadacitinib Versus Tumor Necrosis Factor Inhibitors or Interleukin-17 Inhibitors After First-Line Tumor Necrosis Factor Inhibitors Valentina Carlini¹, Philip Mease², William Tillett³, Xiaolan Ye⁴, Christopher Saffore⁴, Molly Edwards⁵, Isabel Truman⁵, Sophie Barlow⁵, Jayne Stigler⁴, Bhumik Parikh⁴, Daniel Aletaha⁶ | ¹Abbvie srl Roma, Italy; ²University of Washington School of Medicine Seattle, United States Minor Outlying Islands; ³Department of Rheumatology, Royal National Hospital for Rheumatic Diseases Bath, United Kingdom; ⁴Abbvie Inc. North Chicago, United States Minor Outlying Islands; ⁵Adelphi Real World Bollington, United Kingdom; ⁶Division of Rheumatology, Department of Medicine, Medical University of Vienna, Vienna, Austria

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2286

  22

• PO:20:006 | Efficacy of denosumab in glucocorticoid-induced osteoporosis patients with prior exposure to intravenous aminobisphosphonates Kiren Khalid¹, Alessandro Giollo¹, Mariangela Salvato¹, Francesca Frizzera¹, Lorenzo Di Luozzo¹, Bernd Raffeiner², Andrea Doria¹ | ¹Rheumatology Unit, Department of Medicine - DIMED, University of Padova, Padova, Italy; ²Department of Rheumatology, Bolzano Central Hospital, Bolzano, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2341

  18

• PO:02:021 | Sustained Improvements with Bimekizumab in Pain, Morning Stiffness, Fatigue, Physical Function and Health-Related Quality of Life in Patients with Axial Spondyloarthritis: 3-Year Results from Two Phase 3 Studies Victoria Navarro-Compán¹, Uta Kiltz^2|3, Philip J Mease⁴, Maureen Dubreuil⁵, Karl Gaffney⁶, Atul Deodhar⁷, Christine De La Loge⁸, Diana Voiniciuc⁹, Jason Coarse¹⁰, Ilaria Spadafora¹¹, Helena Marzo-Ortega¹² | ¹La Paz University Hospital, IdiPaz, Department of Rheumatology Madrid Spain; ²Ruhr-University Bochum Bochum Germany; ³Rheumazentrum Ruhrgebiet Herne, Germany; ⁴Department of Rheumatology, Swedish Medical Center and Providence St. Joseph Health and University of Washington Seattle, USA; ⁵Boston University School of Medicine, Department of Rheumatology Boston, USA; ⁶Norfolk and Norwich University Hospital NHS Trust, Department of Rheumatology Norfolk, United Kingdom; ⁷Oregon Health and Science University, Division of Arthritis and Rheumatic Diseases Portland, USA; ⁸UCB Brussels, Belgium; ⁹UCB Slough, United Kingdom; ¹⁰UCB Morrisville, USA; ¹¹UCB Milan, Italy; ¹²NIHR Leeds Biomedical Research Centre, University of Leeds Leeds, United Kingdom

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2284

  22

• PO:14:193 | Dapirolizumab Pegol Demonstrated Significant Improvement in Systemic Lupus Erythematosus Disease Activity: Efficacy and Safety Results of a Phase 3 Trial Megan EB Clowse¹, Marta Mosca², David A Isenberg³, Joan T Merrill⁴, Thomas Dörner⁵, Michelle Petri⁶, Edward M Vital^7|8, Eric F Morand⁹, Teri Jimenez¹⁰, Stephen Brookes¹¹, Janine Gaiha-Rohrbach¹², Christophe Martin¹³, Annette Nelde¹⁴, Christian Stach¹⁵ | ¹Duke University - Division of Rheumatology and Immunology Durham, USA; ²University of Pisa - Rheumatology Unit, Department of Clinical and Experimental Medicine Pisa, Italy; ³University College London - Department of Ageing, Rheumatology and Regenerative Medicine, Division of Medicine London, United Kingdom; ⁴Oklahoma Medical Research Foundation Oklahoma City, USA; ⁵Charité Universitätsmedizin Berlin - Department of Medicine/Rheumatology and Clinical Immunology Berlin Germany; ⁶Johns Hopkins University School of Medicine Baltimore, USA; ⁷University of Leeds - Leeds Institute of Rheumatic and Musculoskeletal Medicine Leeds, United Kingdom; ⁸Leeds Teaching Hospitals NHS Trust - NIHR Leeds Biomedical Research Centre Leeds, United Kingdom; ⁹Monash University - Centre for Inflammatory Diseases Melbourne, Australia; ¹⁰UCB Raleigh, USA; ¹¹Biogen Maidenhead, United Kingdom; ¹²Biogen Cambridge, USA; ¹³UCB Slough, United Kingdom; ¹⁴Biogen Baar, Switzerland; ¹⁵UCB Monheim am Rhein, Germany

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2318

  47

• PO:03:034 | Inhibition of Radiographic Progression with Bimekizumab Treatment Observed in bDMARD-Naïve Patients with Active Psoriatic Arthritis at 2 Years: Results from a Phase 3 Study and its Open-Label Extension Laura C Coates¹, M Elaine Husni², Mitsumasa Kishimoto³, Proton Rahman⁴, Philipp Sewerin⁵, Enrique R Soriano⁶, Barbara Ink⁷, Rajan Bajracharya⁷, Jason Coarse⁸, Philip J Mease⁹, Emanuela Mazzola¹⁰, Peter Nash¹¹ | ¹NDORMS, University of Oxford and Oxford Biomedical Research Centre, Oxford University Hospitals NHS Trust Oxford, United Kingdom; ²Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Cleveland, USA; ³Department of Nephrology and Rheumatology, Kyorin University School of Medicine Tokyo, Japan; ⁴Division of Rheumatology, Craig L. Dobbin Genetics Research Centre, Memorial University of Newfoundland St. Johns, Canada; ⁵Rheumazentrum Ruhrgebiet, University Hospital of the Ruhr University Bochum Herne Germany; ⁶Hospital Italiano de Buenos Aires and University Institute Hospital Italiano de Buenos Aires Buenos Aires, Argentina; ⁷UCB Slough, United Kingdom; ⁸UCB Morrisville, USA; ⁹Department of Rheumatology, Providence-Swedish Medical Center and University of Washington Seattle, USA; ¹⁰UCB Milan, Italy; ¹¹School of Medicine, Griffith University, Brisbane, Australia

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2290

  48

• PO:01:006 | Increased risk of cancer recurrence or mortality associated with DMARDs? Laura Scagnellato¹, Giacomo Cozzi¹, Mariagrazia Lorenzin¹, Mariangela Salvato¹, Alessandro Giollo¹, Bernd Raffeiner¹, Antonia Calligaro¹, Teresa Del Ross¹, Sara Bindoli¹, Margherita Zen¹, Paolo Sfriso¹, Andrea Doria¹, Roberta Ramonda¹. | ¹UOC Reumatologia, Dipartimento di Medicina dei Sistemi DIMED, Ospedale Università di Padova, Padova, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2003

  167

• PO:01:007 | Modulation of cellular senescence in psoriatic arthritis: exploring the potential impact of b/tsDMARDs treatment on telomere length, mtDNA copy number, and oxidative damage Eneida Cela¹, Giada De Benedittis², Arianna D'Antonio¹, Andrea Latini³, Chiara Morgante², Cinzia Cicacci³, Paola Conigliaro¹, Mauro Fatica¹, Giulia Mori¹, Giuseppe Novelli², Paola Borgiani², Maria Sole Chimenti¹. | ¹Rheumatology, Allergology and Clinical Immunology, Department of System Medicine, University of Rome Tor Vergata, Rome, Italy; ²Department of Biomedicine and Prevention, Section of Genetics, University of Rome Tor Vergata, Rome, Italy; ³UniCamillus Saint Camillus International University of Health Sciences, Rome, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2004

  161

• PO:06:090 | Validation of 'Clinical Red Flags' for RA-ILD in an Italian cohort: the role fo Dyspnea, Cough and Crackles Eneida Cela¹, Chiara Bonini¹, Francesco Cavalli², Alessandra Luciano³, Barbara Kroegler¹, Josuel Ora², Alberto Bergamini¹, Marcello Chiocchi³, Paola Rogliani², Paola Conigliaro¹, Maria Sole Chimenti¹ | ¹Rheumatology, Allergology and Clinical Immunology, Department of System Medicine, University of Rome Tor Vergata, Rome, Italy; ²Division of Respiratory Medicine, University Hospital Policlinico Tor Vergata, Rome, Italy; ³Department of Diagnostic Imaging and Interventional Radiology, University of Rome, Tor Vergata, Rome, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2302

  18

• PO:26:088 | Rheumatologic immune-related adverse events from immune checkpoint inhibitors: a monocentric retrospective study Giulio Fraticelli^1|2, Nicola Farina^1|2, Alessandro Tomelleri^1|2, Marco Matucci Cerinic^1|2, Corrado Campochiaro^1|2, Lorenzo Dagna^1|2. | ¹Unit of Immunology, Rheumatology, Allergy and Rare Diseases UNIRAR, IRCCS San Raffaele Hospital, Milano, Italy; ²Inflammation, Fibrosis and Ageing Initiative INFLAGE, IRCCS San Raffaele Hospital, Milano, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2065

  140

• PO:08:119 | Infusional Advantage: Rituximab’s Role in Enhancing Adherence in Multimorbid Rheumatoid Arthritis Marco Capodiferro¹, Daniele Domanico¹, Angelica Napoletano¹, Giulia Righetti², Patrizia Suppressa², Vincenzo Venerito¹, Giuseppe Lopalco¹, Florenzo Iannone¹, Fabio Cacciapaglia^1|2 | ¹Rheumatology Unit, Department of Precision and Regenerative Medicine and Jonian Area DiMePRe-J University of Bari, Italy; ²Department of Medicine and Surgery, Miulli General Hospital Acquaviva delle Fonti - LUM University Casamassima Bari Acquaviva delle Fonti, Bari, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2307

  16

• PO:01:008 | Active sacroiliitis at magnetic resonance enterography increases the risk of axial spondyloarthritis in Crohn’s disease patients, while greater age and disease duration are protective factors: a monocentric retrospective cohort study Gabriele Amati¹, Gilda Sandri^1|2, Giovanni Ciancio², Benedetta Bongiovanni^1|2, Martina Orlandi^1|2, Ottavio Secchi^1|2, Davide Vaccari³, Annarita Pecchi⁴, Angela Bertani⁵, Maddalena Pecchini⁵, Pietro Torricelli⁴, Antonio Colecchia⁵, Dilia Giuggioli^1|2. | ¹Struttura Complessa di Reumatologia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy; ²Cattedra di Reumatologia, Università degli studi di Modena e Reggio Emilia, Modena, Italy; ³Unità Operativa di Radiologia, Ospedale di Pavullo, AUSL di Modena, Modena, Italy; ⁴Struttura Complessa di Radiologia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy; ⁵Struttura Complessa di Gastroenterologia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2005

  182

• PO:03:033 | Low Uveitis Rates in Patients with Axial Spondyloarthritis or Psoriatic Arthritis Treated with Bimekizumab: Long-Term Results from Phase 2b/3 Trials Irene E Van Der Horst-Bruinsma¹, Matthew A Brown², Floris A Van Gaalen³, Nigil Haroon⁴, Lianne S Gensler⁵, Alexander Marten⁶, Myriam Manente⁷, George Stojan⁸, Thomas Vaux⁹, Katy White⁹, Atul Deodhar¹⁰, Nicola Boffini¹¹, Martin Rudwaleit¹² | ¹Department of Rheumatology, Radboud University Medical Centre Nijmegen, The Netherlands; ²Genomics England London, United Kingdom; ³Department of Rheumatology, Leiden University Medical Center Leiden, The Netherlands; ⁴Department of Medicine/Rheumatology, University Health Network, Schroeder Arthritis Institute, University of Toronto Toronto, Canada; ⁵Department of Medicine/Rheumatology, University of California San Francisco, USA; ⁶UCB Monheim am Rhein Germany; ⁷UCB Braine-lAlleud, Belgium; ⁸UCB Atlanta, USA; ⁹UCB Slough, United Kingdom; ¹⁰Division of Arthritis and Rheumatic Diseases, Oregon Health and Science University Portland, USA; ¹¹IRCCS Ospedale San Raffaele Milan, Italy; ¹²Klinikum Bielefeld, University of Bielefeld, Bielefeld, Germany

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2289

  21

• PO:04:046 | Achieving Early Clinical Response was Associated with Cumulative Benefits on Disease Impact up to 2 Years in Patients with Active Psoriatic Arthritis Treated with Bimekizumab William Tillett^1|2, Joseph F Merola³, Iain B Mcinnes⁴, Kenneth B Gordon⁵, Richard B Warren⁶, Patrick Healy⁷, Jérémy Lambert⁸, Heather Edens⁹, Barbara Ink¹⁰, Paola Volpe¹¹, Laure Gossec¹² | ¹Royal National Hospital of Rheumatic Diseases Bath, United Kingdom; ²Department of Life Sciences, Centre for Therapeutic Innovation, University of Bath Bath, United Kingdom; ³Department of Dermatology and Department of Medicine, Division of Rheumatology, Utah Southwestern Medical Center Dallas, USA; ⁴College of Medical Veterinary and Life Sciences, University of Glasgow Glasgow, United Kingdom; ⁵Department of Dermatology, Medical College of Wisconsin Milwaukee, USA; ⁶Northern Care Alliance, NHS Foundation Trust and Manchester Academic Health Science Centre, University of Manchester Manchester, United Kingdom; ⁷UCB Morrisville, USA; ⁸UCB Colombes, France; ⁹UCB Smyrna, USA; ¹⁰UCB Slough, United Kingdom; ¹¹UOC Reumatologia, P.O. Spirito Santo Pescara, Italy; ¹²Sorbonne Universite and Pitie-Salpetriere Hospital Paris, France

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2295

  31